Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Terasaki

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Transplantation Proceedings|June 1, 1982
Update of the University of California at San Francisco experience with donor-specific blood transfusionsO Salvatierra, Y Iwaki, F Vincenti, et al.
Journal of the National Cancer Institute|April 1, 1980
Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1)G Klein, J Zeuthen, I Eriksson, et al.
Transplantation|December 1, 1981
An alternative to cadaver kidney transplants for patients with insulin-dependent diabetes mellitusN J Feduska, F Vincenti, W Amend, et al.
Transplantation Proceedings|March 20, 1999
Inhibition of transplant vasculopathy is associated with attenuated host allo-antibody responseM A Maggard, C Johnson, T Wang, et al.
Transplantation|December 1, 1981
Incidence, characteristics, and outcome of recipients sensitized after donor-specific blood transfusionsO Salvatierra, Y Iwaki, F Vincenti, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1980
Panel conference. Cadaver transplantation versus hemodialysisC M Kjellstrand, M M Avram, C R Blagg, et al.
Transplantation Proceedings|March 1, 1981
Improved graft survival with donor-specific transfusion pretreatmentK Cochrum, D Hanes, D Potter, et al.
Transplantation|January 1, 1987
Multivariate analysis of risk factors impacting on immediate and eventual cadaver allograft survival in cyclosporine-treated recipientsB D Kahan, R Mickey, S M Flechner, et al.
Journal of the National Cancer Institute|November 1, 1973
Case-control study of Hodgkin's disease. II. Herpesvirus group antibody titers and HL-A typeB E Henderson, R Dworsky, H Menck, et al.
Transplantation|June 1, 1993
Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantationT E Starzl, A J Demetris, M Trucco, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Transplantation Proceedings|June 1, 1982
Update of the University of California at San Francisco experience with donor-specific blood transfusionsO Salvatierra, Y Iwaki, F Vincenti, et al.
Journal of the National Cancer Institute|April 1, 1980
Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1)G Klein, J Zeuthen, I Eriksson, et al.
Transplantation|December 1, 1981
An alternative to cadaver kidney transplants for patients with insulin-dependent diabetes mellitusN J Feduska, F Vincenti, W Amend, et al.
Transplantation Proceedings|March 20, 1999
Inhibition of transplant vasculopathy is associated with attenuated host allo-antibody responseM A Maggard, C Johnson, T Wang, et al.
Transplantation|December 1, 1981
Incidence, characteristics, and outcome of recipients sensitized after donor-specific blood transfusionsO Salvatierra, Y Iwaki, F Vincenti, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1980
Panel conference. Cadaver transplantation versus hemodialysisC M Kjellstrand, M M Avram, C R Blagg, et al.
Transplantation Proceedings|March 1, 1981
Improved graft survival with donor-specific transfusion pretreatmentK Cochrum, D Hanes, D Potter, et al.
Transplantation|January 1, 1987
Multivariate analysis of risk factors impacting on immediate and eventual cadaver allograft survival in cyclosporine-treated recipientsB D Kahan, R Mickey, S M Flechner, et al.
Journal of the National Cancer Institute|November 1, 1973
Case-control study of Hodgkin's disease. II. Herpesvirus group antibody titers and HL-A typeB E Henderson, R Dworsky, H Menck, et al.
Transplantation|June 1, 1993
Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantationT E Starzl, A J Demetris, M Trucco, et al.
Pageof 8